Delivery Order SPE2DB24D2101-SPE2DB25FKNZV
Award Date 8/27/25
Potential Completion Date 9/18/25
Potential Value $13K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $15,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on July 28, 2025, with an ultimate completion date of August 18, 2025. This non-competitive, non-set-aside delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $47,268.96. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and carries no set-aside designation. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. TUKYSA is a prescription oncology medication, reflecting the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $15,756.32 firm fixed price delivery order for TUKYSA 150 MG tablets (120 count units) on August 18, 2025, with completion scheduled for September 9, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed at the contractor's Conshohocken, Pennsylvania location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a $15,756.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a prescription oncology medication. This delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (60-count units) on August 22, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- The Defense Logistics Agency awarded a $7,846.58 delivery order to AmerisourceBergen Drug Corp for 60 tablets of TUKYSA 50 mg on August 8, 2025, with completion scheduled for August 29, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug TUKYSA 150 MG TABLET, a specialty medication, with a ceiling value of $25,395.38 and a period of performance through May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...